Stockscreener 앱 받기
12.85
0.85%
-0.11
시간 외 거래:
12.85
Zymeworks Inc. 주식(ZYME)의 최신 뉴스
Zymeworks Inc. (NYSE:ZYME) Shares Sold by Envestnet Asset Management Inc. - Defense World
Invesco Ltd. Reduces Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks Inc. (NYSE:ZYME) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Q2 Earnings Forecast for Zymeworks Issued By Leerink Partnrs - Defense World
A new trading data show Zymeworks BC Inc (ZYME) is showing positive returns. - Sete News
Zymeworks (ZYME) Expected to Announce Earnings on Thursday - Defense World
Zymeworks: A Strong Buy With Newly-Approved Cancer Drug, Excellent Financials, And Expansive Pipeline - Seeking Alpha
Zymeworks: Poised For Growth With Platform Validation - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
JPMorgan Chase & Co. Grows Stake in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - Koreabizwire
Zymeworks Presents New Data from Multiple Development Programs a - GuruFocus
Zymeworks Inc. Presents Promising Preclinical Data on Antibody-Drug Conjugates and T Cell Engagers at AACR Annual Meeting 2025 - Nasdaq
Zymeworks Unveils Breakthrough Cancer Drug Data: T-Cell Engagers Show Strong Activity in Lung, Ovarian Cancers - Stock Titan
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - The Financial World
Zymeworks appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development - MediaNews4U
Zymeworks Strengthens Clinical Leadership with New Senior VP Appointment - TipRanks
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Cl - GuruFocus
Zymeworks Strengthens Cancer Drug Pipeline: Top Oncology Expert Takes Helm of Clinical Development - Stock Titan
Major Investment Alert: Ecor1 Capital Boosts Stake in Zymeworks! - TipRanks
Zymeworks to Announce Q1 2025 Financial Results and Host Conference Call - TipRanks
Zymeworks to Report First Quarter 2025 Financial Results and Ho - GuruFocus
Zymeworks Inc. to Announce First Quarter 2025 Financial Results on May 8, 2025 - Nasdaq
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewswire
Clinical-Stage Biotech Zymeworks Sets Q1 2025 Earnings Date: Key Updates Expected - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Yahoo Finance
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
Zymeworks sees $3.62 million stock purchase by EcoR1 Capital - Investing.com Nigeria
Zymeworks Announces Participation in Upcoming Investor Conferences, Business Wires News - AsiaOne
Zymeworks Inc. sees insider purchases totaling $1.5 million By Investing.com - Investing.com South Africa
Major Investment Alert: Director Buys Big in Zymeworks! - TipRanks
Zymeworks Inc. sees insider purchases totaling $1.5 million - Investing.com
Ecor1 Capital, Llc Purchases 22,689 Shares of Zymeworks Inc. (NYSE:ZYME) Stock - MarketBeat
Major Investment Alert: Ecor1 Capital Buys Big in Zymeworks! - TipRanks
Ecor1 Capital’s Oleg Nodelman buys $1.23 million in Zymeworks stock By Investing.com - Investing.com Canada
Zymeworks to Engage Investors at Upcoming Conferences - TipRanks
Zymeworks Announces Participation in Upcoming Investor Conferences - The Manila Times
Clinical-Stage Biotech Zymeworks Reveals New Pipeline Insights at Two Major Healthcare Conferences - Stock Titan
Zymeworks to Present Promising Cancer Therapy Data at AACR Meeting - TipRanks
Zymeworks to Present Preclinical Data on T cell Engager and - GlobeNewswire
Game-Changing Cancer Drug Results: Zymeworks Reveals 6 Promising Treatments at AACR - Stock Titan
Zymeworks Inc. (ZYME): Among Stocks Receiving the Most Insider Love in March - Insider Monkey
0.39%
3.66%
자본화:
|
볼륨(24시간):